Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Schedule 2 products - PAAB guidelines for promotional material
-
We are marketing a Schedule 2 product (non-prescription, HC regulated) that can also be prescribed (to allow for coverage via a drug plan) and wanted to know the guidelines for branded and unbranded promotional materials when it comes to this type of Schedule 2 products.
-
Hello @ap
Schedule 2 in this case appears to be referring to NAPRA. For drug advertising, one should refer to Health Canada schedules.
Since the question was posted under the category “DTCI” we will assume you’re asking about the consumer regulations. The Food and Drug Regulations, Food and Drug Act, relation to conditions listed on Schedule A and the Health Canada document Therapeutic Comparative Advertising: Directive and Guidance Document should be applied.
For content directed to healthcare professionals, the PAAB Code applies and all aspects of the Code should be met.
